- Home
- ATXS vs CCSI Comparison
ATXS vs CCSI Comparison
Compare ATXS & CCSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- CCSI
- Stock Information
- Founded
- ATXS 2008
- CCSI 2021
- Country
- ATXS United States
- CCSI United States
- Employees
- ATXS N/A
- CCSI N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- CCSI Retail: Computer Software & Peripheral Equipment
- Sector
- ATXS Health Care
- CCSI Technology
- Exchange
- ATXS Nasdaq
- CCSI Nasdaq
- Market Cap
- ATXS 401.2M
- CCSI 475.1M
- IPO Year
- ATXS 2015
- CCSI N/A
- Fundamental
- Price
- ATXS $5.34
- CCSI $23.08
- Analyst Decision
- ATXS Strong Buy
- CCSI Hold
- Analyst Count
- ATXS 5
- CCSI 5
- Target Price
- ATXS $26.60
- CCSI $27.20
- AVG Volume (30 Days)
- ATXS 276.5K
- CCSI 155.0K
- Earning Date
- ATXS 03-11-2025
- CCSI 05-07-2025
- Dividend Yield
- ATXS N/A
- CCSI N/A
- EPS Growth
- ATXS N/A
- CCSI 17.26
- EPS
- ATXS N/A
- CCSI 4.62
- Revenue
- ATXS N/A
- CCSI $350,382,000.00
- Revenue This Year
- ATXS N/A
- CCSI $1.32
- Revenue Next Year
- ATXS N/A
- CCSI $0.83
- P/E Ratio
- ATXS N/A
- CCSI $5.02
- Revenue Growth
- ATXS N/A
- CCSI N/A
- 52 Week Low
- ATXS $5.29
- CCSI $11.62
- 52 Week High
- ATXS $14.04
- CCSI $32.10
- Technical
- Relative Strength Index (RSI)
- ATXS 28.85
- CCSI 38.86
- Support Level
- ATXS $5.89
- CCSI $23.42
- Resistance Level
- ATXS $6.52
- CCSI $24.90
- Average True Range (ATR)
- ATXS 0.40
- CCSI 0.84
- MACD
- ATXS -0.06
- CCSI -0.03
- Stochastic Oscillator
- ATXS 2.50
- CCSI 25.10
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.